Methomyl


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0000212 Meiotic spindle organization Affects phenotype PMID:34676817
GO:0001556 Oocyte maturation Affects phenotype PMID:34676817
GO:0004035 Alkaline phosphatase activity Increases phenotype PMID:28425351
GO:0004069 L-aspartate:2-oxoglutarate aminotransferase activity Increases phenotype PMID:28425351
GO:0005975 Carbohydrate metabolic process Affects phenotype PMID:28425351
GO:0006012 Galactose metabolic process Affects phenotype PMID:28425351
GO:0006014 D-ribose metabolic process Affects phenotype PMID:28425351
GO:0006020 Inositol metabolic process Affects phenotype PMID:28425351
GO:0006560 Proline metabolic process Affects phenotype PMID:28425351
GO:0006633 Fatty acid biosynthetic process Affects phenotype PMID:28425351
GO:0010867 Positive regulation of triglyceride biosynthetic process Increases phenotype PMID:39742927
GO:0010940 Positive regulation of necrotic cell death Increases phenotype PMID:39742927
GO:0010983 Positive regulation of high-density lipoprotein particle clearance Increases phenotype PMID:39742927
GO:0015939 Pantothenate metabolic process Affects phenotype PMID:28425351
GO:0019216 Regulation of lipid metabolic process Affects phenotype PMID:39742927
GO:0019321 Pentose metabolic process Affects phenotype PMID:28425351
GO:0019752 Carboxylic acid metabolic process Affects phenotype PMID:28425351; PMID:38734222
GO:0040038 Polar body extrusion after meiotic divisions Affects phenotype PMID:34676817
GO:0042573 Retinoic acid metabolic process Affects phenotype PMID:28425351
GO:0042732 D-xylose metabolic process Affects phenotype PMID:28425351
GO:0050729 Positive regulation of inflammatory response Increases phenotype PMID:39742927
GO:0050996 Positive regulation of lipid catabolic process Increases phenotype PMID:39742927
GO:0051882 Mitochondrial depolarization Increases phenotype PMID:34676817
GO:0072350 Tricarboxylic acid metabolic process Affects phenotype PMID:28425351
GO:0072593 Reactive oxygen species metabolic process Affects phenotype PMID:34676817
GO:0090306 Meiotic spindle assembly Affects phenotype PMID:34676817
GO:1900533 Palmitic acid metabolic process Affects phenotype PMID:28425351
GO:1901334 Lactone metabolic process Affects phenotype PMID:28425351
GO:1903787 Negative regulation of glutathione biosynthetic process Increases phenotype PMID:39742927
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.